Why Retatrutide Draws Disproportionate Research Attention
Across published GLP-class compounds, Retatrutide currently produces the highest single-agent weight effect in Phase 2 data — −28.7% at 48 weeks at the top dose. That number is not incremental over the dual-agonist class; it is a meaningful step up that has shifted research attention.
The compound is available as GLP-3 R 15mg Retatrutide for standard research protocols and in larger formats for extended study designs.
Triple-Receptor Architecture
Retatrutide engages three receptors simultaneously, each contributing a distinct pathway:
- GLP-1R: Hypothalamic appetite suppression, glucose-dependent insulin secretion, gastric emptying delay
- GIPR: Potentiates GLP-1R insulin signaling, reduces nausea axis overlap, modulates adipose signaling
- GcgR: Hepatic glucose modulation and thermogenic energy expenditure — the axis not present in tirzepatide
The GcgR contribution is what structurally separates Retatrutide from the dual-agonist class. Phase 2 attributed roughly 6–8 percentage points of additional weight effect to the glucagon axis above tirzepatide's baseline.
Phase 2 Dose-Response Summary
| Weekly Dose | Mean % Weight Change | Duration |
|---|---|---|
| 1mg | −8.7% | 48 wks |
| 4mg | −17.3% | 48 wks |
| 8mg | −22.8% | 48 wks |
| 12mg | −24.2% | 48 wks |
| 24mg | −28.7% | 48 wks |
The curve shows clear dose-dependence without obvious plateau within the studied range.
How Protocols Typically Stage Retatrutide
Researchers generally follow the trial titration rhythm: begin low, escalate every 4 weeks, and hold at the target dose for the remaining protocol window. Dose escalation is the primary lever for reducing GI tolerability issues during initiation.
Purchasing and Handling Notes
Research-grade Retatrutide should carry >98% HPLC purity certification with third-party test reports available. The lyophilized powder is stable at −20°C long-term; reconstituted solutions should be held at 2–8°C and used within 28 days.
To start a Retatrutide research protocol, browse GLP-3 R 15mg Retatrutide.